Drug-target interactions and molecular design

A molecular design starts with a defined material

A drug-target interaction is one part of how a candidate molecule may act. Functional groups, charge state, stereochemical composition, conformational preferences and the target’s state can affect recognition. A molecular formula alone does not define every relevant property of the material.

Enantiomers have different spatial arrangements in a chiral setting and can differ in binding or disposition. Assigning an actual R or S configuration requires a defined structure and priority rules. The symbolic A/ent-A pair used here specifies composition and assigned affinities, without inventing an actual structure or clinical comparison.

Binding ratios and prescribed target exposure answer different questions

For two invented targets in compatible one-site in-vitro conditions, assign K_d values 14.0 and 1,400 nmol L⁻¹. The off-target/target K_d ratio is 100. At free ligand 28.0 nmol L⁻¹, occupancies are 28/(14+28)=0.666666667 and 28/(1,400+28)=0.0196078431.

Raising free ligand to 280 nmol L⁻¹ changes them to 0.952380952 and 0.166666667. The affinity ratio remains 100, but it does not prevent appreciable off-target occupancy at a larger free concentration. No untested-target selectivity or clinical effect has been established.

For a separate hypothetical steady exposure model, assign total well ligand 0.630 μmol L⁻¹, outside unbound fraction 0.120 and inside/outside free-concentration ratio 0.350. Outside free concentration is 0.0756 μmol L⁻¹ and prescribed inside free concentration 0.02646 μmol L⁻¹. This is an assigned exposure relation, rather than a measured transport model.

With compatible target K_d=0.0180 μmol L⁻¹, one-site equilibrium occupancy at that prescribed inside free concentration is 0.595141700. Using total well concentration as target free instead gives 0.972222222. Reducing only the inside/outside free ratio tenfold to 0.0350 gives inside free 0.002646 μmol L⁻¹ and occupancy 0.128160418, even though the nominal total remains unchanged.

Affinity needs an assay and a comparison

A smaller equilibrium K_d in a compatible simple assay denotes stronger binding under that model’s conditions. A ratio of affinities for two tested targets gives a bounded selectivity comparison. It does not establish selectivity against untested targets or unique downstream effects.

For reversible binding, association and dissociation rate constants can give an equilibrium ratio under their specified kinetic model. A slow dissociation rate can extend persistence after free ligand is removed. Equilibrium affinity, kinetic persistence and biological efficacy are distinct properties.

The same equilibrium affinity can have different time courses

Choose two invented one-step binding systems at maintained free ligand L=48.0 nmol L⁻¹. Assign association rate constants k_on=0.0150/0.00150 L nmol⁻¹ min⁻¹ and dissociation k_off=0.360/0.0360 min⁻¹. Both give K_d=k_off/k_on=24.0 nmol L⁻¹ and equilibrium occupancy θ_eq=2/3.

Starting unbound, define θ(t)=θ_eq[1−exp(−λt)], where λ=k_onL+k_off is 1.08/0.108 min⁻¹. At one minute occupancies are 0.440269650 and 0.0682482690. Equal equilibrium affinities do not establish equal finite-time association.

For the graph’s separate initial condition, start both at equilibrium, then mathematically set free ligand to zero and exclude rebinding. Occupancy becomes θ_eqexp(−k_offt). After six minutes it is 0.0768834140 in the faster-dissociating system and 0.537156868 in the slower one. This prescribed no-rebinding change is a kinetic comparison, not an actual dosing or washout procedure.

For another symbolic one-site model, take mirror-related A and ent-A without a real molecular graph or assigned CIP configurations. Maintain total free mixture 100 nmol L⁻¹ with A fraction 0.350: free A=35.0 and ent-A=65.0 nmol L⁻¹. Assign K_d,A=8.00 and K_d,ent-A=2,000 nmol L⁻¹ under compatible conditions.

The empty/A-bound/ent-A-bound weights are 1, 35/8 and 65/2,000. Fractions are 0.184928340, 0.809061489 and 0.00601017106. Stipulate a normalized readout to which only bound A contributes; it is 0.809061489. Pure free A at the same total gives 0.925925926 in this assigned model. The stipulated zero contribution of ent-A to this one readout is not a general statement about real enantiomers or evidence of a treatment advantage.

A nominal concentration does not establish target exposure

Added material can distribute among medium, proteins, membranes and other compartments or undergo transformation. The free concentration at the target can differ from both the amount added and the total concentration measured in a bulk sample.

A conditional exposure model can use assigned unbound fractions and transport relationships to illustrate that distinction. Real transport, sequestration, metabolism and time dependence require evidence for the actual system. A binding curve cannot by itself fill those gaps.

An improved molecular property needs wider testing

Improving a measured affinity or another selected property can create trade-offs in solubility, chemical stability, access, selectivity or metabolism. An observed cellular change should be linked to target engagement and controls that test alternative causes.

The transition to a useful medicine also requires evidence of benefit, harms and suitable use in the intended context. The original numerical comparisons in this lesson demonstrate model reasoning; they contain no actual treatment, dose recommendation or claim that one candidate is safe or effective.

Worked examples

Try it yourself

1. Raise free ligand to 280 nmol L⁻¹ in the affinity comparison. Find both occupancies and whether the 100-fold ratio prevents off-target binding.

   Show the answer and reasoning

   Target 0.952380952; off-target 0.166666667; the affinity ratio remains 100 and does not prevent appreciable off-target occupancy.

   Use L/(K_d+L) for each defined target at the new maintained free concentration.

2. Reduce only the assigned inside/outside free ratio to 0.0350. Find inside free ligand and occupancy, with total well ligand unchanged.

   Show the answer and reasoning

   Inside free 0.002646 μmol L⁻¹; occupancy 0.128160418; total remains 0.630 μmol L⁻¹.

   Multiply the same outside free concentration by the new ratio; occupancy is nonlinear in exposure.

3. Start both kinetic systems at equilibrium, then mathematically set free ligand to zero and exclude rebinding. Find occupancies after six minutes.

   Show the answer and reasoning

   Faster 0.0768834140; slower 0.537156868.

   Multiply θ_eq=2/3 by exp(−k_off×6); equal equilibrium affinity does not establish equal persistence.

4. Replace the symbolic mixture by pure free A at the same total 100 nmol L⁻¹. Find occupancy and assigned readout. Does clinical advantage follow?

   Show the answer and reasoning

   A-bound occupancy and assigned readout are 0.925925926. Clinical advantage does not follow.

   The one-ligand limit is 100/(100+8). It changes this stipulated interaction and readout only.

What to carry forward

• Affinity, selectivity, access and functional response answer different questions.
• Use the free concentration at the specified target location.
• A shared equilibrium constant can accompany different approach and exit rates.
• A mixture of stereoisomers requires the stated composition and activity evidence.